Heyu Biological Technology
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Heyu Biological Technology's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 18% to $78,953. Profit margin reached -336%. Total operating expenses were $317,347.

Profit Margin

Heyu Biological Technology Corporation (OTC:HYBT): Profit margin
2013 1.66M -3.68M -221.28%
2014 6.57M -498.81K -7.58%
2015 3.17M -3.54M -111.48%
2016 188.21K -158.50K -84.22%
2017 0 -54.11K
2018 0 -247.77K
2019 163.68K -488.38K -298.38%
2020 222.70K -548.39K -246.25%
2021 96.47K -163.02K -168.97%
2022 78.95K -265.37K -336.12%

HYBT Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
78.95K96.47K222.70K163.68K00188.21K3.17M6.57M1.66M
Cost of revenue
27.38K30.31K118.52K83.57K0069.96K2.79M4.85M727.88K
Gross profit
51.56K66.16K104.17K80.10K00118.25K385.60K1.72M936.21K
Operating exp.
Research and development
00000054.19K214.85K225.01K236.26K
Selling and marketing
4041.28K6.86K23.79K0032.96K136.86K206.65K169.35K
Total operating expenses
317.34K228.99K382.95K618.22K247.77K54.11K406.15K1.97M2.23M1.67M
Operating income
-265.77K-162.83K-278.78K-538.12K-247.77K-54.11K-287.9K-1.59M-509.37K-737.04K
Other income (expenses), net
200-184-474.35K-1.88K00130.40K-1.94M10.56K-502.95K
Income before tax
-265.57K-163.02K-753.14K-540.01K-247.77K-54.11K-158.50K-3.54M-498.81K-1.18M
Income tax expense
-2000-204.74K-51.62K001.01K1.94M02.49M
Net income
-265.37K-163.02K-548.39K-488.38K-247.77K-54.11K-158.50K-3.54M-498.81K-3.68M
Earnings per share
Basic EPS
-0.00-0.00-0.00-0.00-0.00-0.00-0.15-3.31-0.47-0.34
Diluted EPS
-0.00-0.00-0.00-0.00-0.00-0.00-0.15-3.31-0.47-0.34
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source